TGTX - TG Therapeutics spikes as Merck KgaA flunks multiple sclerosis trial
2023-12-06 10:11:00 ET
More on TG Therapeutics
- TG Therapeutics: Trying To Fill The Gap Back To $20
- TG Therapeutics, Inc. (TGTX) Q3 2023 Earnings Call Transcript
- TG Therapeutics: Q3 Earnings Spike Hard To Explain Given Rival's Numbers
- TG Therapeutics gains after strong Q3 beat
- TG Therapeutics Q3 2023 Earnings Preview
For further details see:
TG Therapeutics spikes as Merck KgaA flunks multiple sclerosis trial